Right to health activists demand release of the full text of EU-India trade deal

The Working Group connected Access to Medicines and Treatment, reacting to the caller decision of negotiations for the EU-India Free Trade Agreement (FTA), said that determination is nary clarity connected aesculapian attraction oregon medicine patent related provisions. It besides does not clarify whether the statement includes measures specified arsenic patent word extensions, pharmaceutical information exclusivity, oregon different forms of marketplace exclusivity for drugs. “This deficiency of clarity is simply a superior interest and involves hazard of having a nonstop oregon indirect interaction connected entree to affordable medicines,” it warned.

The radical which works connected entree to medicines and attraction further said that India has agreed to IP extortion and enforcement standards that spell beyond the minimum obligations nether the WTO Agreement connected Trade-Related Aspects of Intellectual Property (TRIPS Agreement). However, erstwhile negotiations were relaunched successful 2022, the European Union’s projected IP substance explicitly sought patent word hold and information exclusivity extortion for pharmaceutical products. 

“In the erstwhile rounds of negotiations peculiarly during 2007-2013, India had rejected these TRIPS-plus demands pursuing beardown absorption from civilian society, patent groups, and nationalist wellness advocates,” the radical said.

We impulse the Indian Government to clarify and guarantee that the last substance does not see immoderate TRIPS-plus provisions, peculiarly patent word extensions, and information exclusivity, which would compromise the availability of affordable medicines. The radical has besides sought contiguous merchandise of the afloat text of the statement to let elaborate discussions.